Haoxi Health Technology Limited Class A (HAO) has released an update.
Haoxi Health Technology Limited has received a notification from Nasdaq regarding a failure to comply with the minimum bid price requirement, which could affect its listing status. The company has until April 2025 to rectify the situation, potentially through measures like a reverse share split. Despite this challenge, Haoxi’s business operations remain unaffected as it continues to serve the healthcare industry with its online marketing solutions.
For further insights into HAO stock, check out TipRanks’ Stock Analysis page.
